MEPSEVII 2 mg/mL
vestronidase alfa · INJECTION · Ultragenyx Pharmaceutical Inc.
No Recall History
Plain English
MEPSEVII is a injection containing vestronidase alfa at 2 mg/mL, taken intravenous. Manufactured by Ultragenyx Pharmaceutical Inc..
Key Facts
- Brand Name
- MEPSEVII
- Generic Name
- vestronidase alfa
- NDC Code (Product)
69794-001- Manufacturer
- Ultragenyx Pharmaceutical Inc.
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761047
- Drug Class
- Lysosomal beta Glucuronidase [EPC]
- Marketing Start
- 11/15/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is MEPSEVII used for?
MEPSEVII contains vestronidase alfa. It is a injection taken intravenous. Consult your doctor for specific uses.
Is MEPSEVII a controlled substance?
MEPSEVII is not classified as a controlled substance by the DEA.
What is the generic name for MEPSEVII?
The generic name for MEPSEVII is vestronidase alfa. There are no other listed brand versions of vestronidase alfa.
What is the NDC code for MEPSEVII 2 mg/mL?
The NDC (National Drug Code) for MEPSEVII 2 mg/mL is 69794-001, listed by Ultragenyx Pharmaceutical Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)